TransMedics (TMDX) Reports Asset Acquisition/Disposition Completion
Ticker: TMDX · Form: 8-K · Filed: Jan 29, 2024 · CIK: 1756262
| Field | Detail |
|---|---|
| Company | Transmedics Group, Inc. (TMDX) |
| Form Type | 8-K |
| Filed Date | Jan 29, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $13.1 million |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: acquisition, asset-disposition, corporate-action
TL;DR
**TMDX just completed a major asset transaction, watch for details on impact.**
AI Summary
TransMedics Group, Inc. (TMDX) filed an 8-K on January 29, 2024, to report the completion of an acquisition or disposition of assets, with the earliest event reported on January 25, 2024. This filing indicates a significant change in the company's asset structure, which could impact its future financial performance and strategic direction. Investors should pay attention to the details of this transaction as it may affect the company's growth prospects and overall valuation.
Why It Matters
This filing signals a material change in TransMedics' business operations, potentially altering its revenue streams, cost structure, or market position. Understanding the nature of this transaction is crucial for assessing the company's future profitability and competitive landscape.
Risk Assessment
Risk Level: medium — The risk level is medium because while the filing indicates a completed transaction, the specific details of the acquisition or disposition are not provided, making it difficult to assess the full financial and strategic implications.
Analyst Insight
A smart investor would await further details regarding the specific assets acquired or disposed of, including their value and strategic rationale, before making any investment decisions. This filing is a notification of an event, not a full disclosure of its impact.
Key Players & Entities
- TransMedics Group, Inc. (company) — the registrant filing the 8-K
- January 25, 2024 (date) — date of the earliest event reported
- January 29, 2024 (date) — date the 8-K was filed
- 001-38891 (other) — Commission File Number for TransMedics Group, Inc.
- TMDX (other) — Trading Symbol for TransMedics Group, Inc.
FAQ
What specific type of event did TransMedics Group, Inc. report in this 8-K filing?
TransMedics Group, Inc. reported the "Completion of Acquisition or Disposition of Assets" as per the Item Information in the 8-K filing.
When was the earliest event reported in this 8-K filing by TransMedics Group, Inc.?
The earliest event reported in this 8-K filing was on January 25, 2024, as stated under "Date of Report (Date of earliest event reported)".
What is the trading symbol for TransMedics Group, Inc. as listed in the filing?
The trading symbol for TransMedics Group, Inc. is TMDX, as indicated under "Securities registered pursuant to Section 12(b) of the Act: Trading Symbol(s)".
On which exchange is TransMedics Group, Inc.'s Common Stock registered?
TransMedics Group, Inc.'s Common Stock is registered on The Nasdaq Global Market, as stated under "Name of each exchange on which registered" in the filing.
What is the business address of TransMedics Group, Inc. according to the filing?
The business address of TransMedics Group, Inc. is 200 Minuteman Road, Andover, Massachusetts, 01810, as listed under "BUSINESS ADDRESS" in the filing.
Filing Stats: 583 words · 2 min read · ~2 pages · Grade level 13.6 · Accepted 2024-01-29 16:05:58
Key Financial Figures
- $13.1 million — . for a purchase price of approximately $13.1 million (together with the Prior Acquisitions,
Filing Documents
- d745550d8k.htm (8-K) — 24KB
- 0001193125-24-018104.txt ( ) — 139KB
- tmdx-20240125.xsd (EX-101.SCH) — 3KB
- tmdx-20240125_lab.xml (EX-101.LAB) — 17KB
- tmdx-20240125_pre.xml (EX-101.PRE) — 11KB
- d745550d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRANSMEDICS GROUP, INC. Date: January 29, 2024 By: /s/ Stephen Gordon Name: Stephen Gordon Title: Chief Financial Officer and Treasurer